Biotechnology News

Allogenetics today announced the appointment of Jeroen Rovers, MD, PhD, as Chief Medical Officer.

Company announcement no. 26 - 2621 July 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as...

Validation du procédé de biorecyclage « fibre-à-fibre », dans des conditions représentatives d’une exploitation industrielle100ème batch1 produit avec succès au sein du démonstrateur de...

Validation of the "Fiber-to-Fiber" biorecycling process under conditions representative of industrial operations100th batch1 successfully produced at the Clermont-Ferrand demonstration plantMore...

SAN DIEGO, July 20, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a biotechnology company pioneering the development of targeted genetic...

MALVERN, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...

Three new Genome British Columbia projects involve developing tools to help growers protect British Columbia's valuable crops from pests and pathogens.

Applied Biologics announces submission of XWRAP® translational research abstract to SAWC Fall 2026.

SYDNEY, July 20, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) today announces that results from its proof-of-concept trial, entitled “A phase 2 randomised, double-blind,...

Enozertinib poster presentation to highlight data from an ongoing Phase 1b trial in first-line EGFR atypical NSCLC Rinzimetostat trial-in-progress poster presentation to highlight the ongoing...